Mariliis Ott
YOU?
Author Swipe
View article: P-700. Examining the Knowledge, Availability, Access and Uptake of RSV Immunoprophylasis among RSV Hospitalized Infants
P-700. Examining the Knowledge, Availability, Access and Uptake of RSV Immunoprophylasis among RSV Hospitalized Infants Open
Background Every year, up to 80,000 children less than 5 years are hospitalized due to RSV infection and those less than 1 are at greatest risk for ICU admission. In the Fall of 2023, 2 immunoprophylaxis strategies, nirsevimab for infants …
View article: Expansion of the HSV-2–specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine
Expansion of the HSV-2–specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine Open
The skin at the site of HSV-2 reactivation is enriched for HSV-2-specific T cells. To evaluate whether an immunotherapeutic vaccine could elicit skin-based memory T cells, we studied skin biopsies and HSV-2-reactive CD4+ T cells from PBMCs…
View article: Data from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Data from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Merkel cell carcinoma (MCC) is often caused by persistent expression of Merkel cell polyomavirus (MCPyV) T-antigen (T-Ag). These non-self proteins comprise about 400 amino acids (AA). Clinical responses to immune checkpoint inhibitors, see…
View article: Data from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Data from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Merkel cell carcinoma (MCC) is often caused by persistent expression of Merkel cell polyomavirus (MCPyV) T-antigen (T-Ag). These non-self proteins comprise about 400 amino acids (AA). Clinical responses to immune checkpoint inhibitors, see…
View article: Supplementary Figures from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Supplementary Figures from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Sup Figures 1-13
View article: Supplementary Tables from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Supplementary Tables from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Sup Tables 1-6
View article: Supplementary Tables from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Supplementary Tables from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Sup Tables 1-6
View article: Supplementary Figures from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Supplementary Figures from Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8<sup>+</sup> T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Sup Figures 1-13
View article: Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection
Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection Open
Importance Herpes simplex virus type 1 (HSV-1) is the leading cause of first-episode genital herpes in many countries. Objective To inform counseling messages regarding genital HSV-1 transmission, oral and genital viral shedding patterns a…
View article: Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine Open
The skin at the site of HSV-2 reactivation is enriched for HSV-2-specific T cells. To evaluate whether an immunotherapeutic vaccine could elicit skin-based memory T cells, we studied skin biopsies and HSV-2-reactive CD4 + T cells from peri…
View article: Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas
Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas Open
Merkel cell carcinoma (MCC) is often caused by persistent expression of Merkel cell polyomavirus (MCPyV) T-antigen (T-Ag). These non-self proteins comprise about 400 amino acids (AA). Clinical responses to immune checkpoint inhibitors, see…
View article: Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time
Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time Open
Here we present genomic and in vitro analyses of temporally separated episodes of herpes simplex virus type 1 (HSV-1) shedding by an HSV-1-seropositive and human immunodeficiency virus (HIV)/HSV-2-seronegative individual who has frequent r…
View article: T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis
T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis Open
Background: Herpes simplex encephalitis (HSE) after primary herpes simplex virus (HSV)-1 infection can occur in children due to inborn errors of cell-intrinsic immunity in the central nervous system. Paradoxically, symptomatic mucocutaneou…
View article: Mucosal Shedding and Cellular Immune Response After First Episode Genital Herpes Simplex Virus Type 1 Infection
Mucosal Shedding and Cellular Immune Response After First Episode Genital Herpes Simplex Virus Type 1 Infection Open
Herpes simplex virus type 1 (HSV-1) is the leading cause of first episode genital herpes in the USA. Despite an often severe primary episode, recurrences and viral shedding are less frequent in genital HSV-1 than in genital HSV-2 infection…